Author:
Mandke A,Gajendragadkar S,Hegde A,Amaria T,Mandke N
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference17 articles.
1. Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994; 107: 554–61.
2. Royston D, Bidstrup BP, et al. Aprotinin prevents bleeding and has effects on platelets and fibrinolysis. J Cadriothor Vasc Anesth 1991; 5: 18–23.
3. Cosgrove DM, Heric B, Lytie BW, et al. Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 1992; 54: 1036–38.
4. Levy JH, Pifarre R, Schaff H, et al. A multicenter, placebo-controlled, double blind trial of aprotinin for repeat coronary artery bypass grafting. Circulation 1995; 92: 2236–44.
5. Alderman EL, Levy JH, Schaff H. International multi center aprotinin graft patency experience (IMAGE). J Thorac Cardiovasc Surg 1998; 116: 716–30.